Inventor
Robert Gilfillan
Inventor
Newhouse, GB
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes12%
C07BGeneral methods of organic chemistry6%
C07CAcyclic or carbocyclic compounds6%
C07KPeptides6%
PatentTitleYear
9,718,819'Non-nucleoside reverse transcriptase inhibitors'20178,299,091'Aminoisoquinoline thrombin inhibitor with improved bioavailability'20128,034,804'(Pyrido/thieno)-[f]-oxazepine-5-one derivatives'20117,566,778'(Pyrido/thieno)-[f]-oxazepine-5-one derivatives'20097,345,036'(Pyrido/thieno)—[f]—oxazepine-5-one derivatives'20086,410,592'Aminomethylcarboxylic acid derivatives'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002Patents assigned to AKZO NOBEL NV (1)· patent assignee history
2002–2008Based in Scotland, GB· patent location history
2008–2011Patents assigned to ORGANON NV (3)· patent assignee history
2009–2012Based in Newhouse, GB· patent location history
2012Patents assigned to BENNETT DAVID JONATHAN (1)· patent assignee history
2012Patents assigned to GILFILLAN ROBERT (1)· patent assignee history
2017Patents assigned to MERCK SHARP & DOHME (1)· patent assignee history
2017Based in Lexington, MA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ORGANON NV | 3 | 2008–2011 |
| AKZO NOBEL NV | 1 | 2002 |
| BENNETT DAVID JONATHAN | 1 | 2012 |
| GILFILLAN ROBERTself | 1 | 2012 |
| MERCK SHARP & DOHME | 1 | 2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newhouse, GB | 3 | 2009–2012 |
| Scotland, GB | 2 | 2002–2008 |
| Lexington, Massachusetts, US | 1 | 2017 |